Us Bancorp \De\ Rhythm Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$73 Billion
Q2 2024

A detailed history of Us Bancorp \De\ transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 141 shares of RYTM stock, worth $7,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141

Previous 62 127.42%

Holding current value

$7,240

Previous $2,000 150.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$35.41 - $44.37 $2,797 - $3,505	79 Added 127.42%	141 $5,000
Q4 2023 Feb 09, 2024	SELL	$21.39 - $49.64 $1,026 - $2,382	-48 Reduced 43.64%	62 $2,000
Q3 2023 Nov 03, 2023	SELL	$15.81 - $27.8 $15,066 - $26,493	-953 Reduced 89.65%	110 $2,000
Q2 2023 Aug 09, 2023	BUY	$16.32 - $21.15 $16,613 - $21,530	1,018 Added 2262.22%	1,063 $17,000
Q3 2022 Oct 27, 2022	BUY	$4.3 - $30.85 $193 - $1,388	45 New	45 $1,000
Q2 2022 Aug 01, 2022	SELL	$3.12 - $12.25 $405 - $1,592	-130 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$6.13 - $12.24 $18,598 - $37,136	-3,034 Reduced 95.89%	130 $1,000
Q4 2021 Feb 11, 2022	BUY	$8.62 - $13.9 $26,446 - $42,645	3,068 Added 3195.83%	3,164 $32,000
Q3 2021 Nov 10, 2021	SELL	$11.68 - $20.72 $467 - $828	-40 Reduced 29.41%	96 $1,000
Q2 2021 Aug 05, 2021	SELL	$18.52 - $22.55 $6,630 - $8,072	-358 Reduced 72.47%	136 $3,000
Q1 2021 Apr 28, 2021	SELL	$20.25 - $39.49 $6,783 - $13,229	-335 Reduced 40.41%	494 $11,000
Q4 2020 Feb 04, 2021	BUY	$21.17 - $32.61 $7,790 - $12,000	368 Added 79.83%	829 $25,000
Q3 2020 Nov 10, 2020	BUY	$18.13 - $30.61 $6,454 - $10,897	356 Added 339.05%	461 $10,000
Q2 2020 Aug 07, 2020	BUY	$14.41 - $25.35 $1,513 - $2,661	105 New	105 $2,000
Q2 2019 Aug 13, 2019	SELL	$21.11 - $28.48 $2,089 - $2,819	-99 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$24.76 - $31.66 $2,451 - $3,134	99 New	99 $3,000

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account